Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Jordana Zwerling, MA
JCP
Letter to the Editor
Rapastinel (GLYX-13) Effects in OCD
February 21, 2018
Read a study investigating the effects of rapastinel administration on 7 patients with OCD.
Omer Linkovski
,
Hanyang Shen
,
Jordana Zwerling
, et al
JCP
Letter to the Editor
Challenges in Testing Intranasal Ketamine in OCD
April 26, 2017
Reports have indicated that a single intravenous ketamine dose rapidly decreases OCD symptoms. These researchers planned a study of nasal ketamine administration for this purpose, but they quickly encountered...
Carolyn I. Rodriguez
,
Kyle A. B. Lapidus
,
Jordana Zwerling
, et al
JCP
Letter to the Editor
Memantine in OCD
May 25, 2016
Ketamine may reduce OCD symptoms in some patients, but IV administration is undesirable. Learn whether oral memantine, another NMDA receptor antagonist, would be a good alternative.
Carolyn I. Rodriguez
,
Amanda Levinson
,
Jordana Zwerling
, et al
JCP
Letter to the Editor
Can Exposure-Based CBT Extend the Effects of Intravenous Ketamine in Obsessive-Compulsive Disorder? An Open-Label Trial
March 23, 2016
Carolyn I. Rodriguez
,
Michael Wheaton
,
Jordana Zwerling
, et al
